| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire? | 23 | The Motley Fool | ||
| Fr | If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today | 13 | The Motley Fool | ||
| Do | Neue Analysteneinschätzung - Carbon Done Right Developments, Bristol Myers Squibb, Deutsche Lufthansa Aktie | 812 | Der Finanzinvestor | Negative Wirtschaftsdaten aus den USA belasteten zuletzt die Indizes. Das abschwächende Wirtschaftswachstum in den USA, wie auch die anhaltende Inflation treiben immer mehr Anlegern die Sorgenfalten... ► Artikel lesen | |
| Mi | Bristol Myers Squibb and Repertoire enter autoimmune disease partnership worth over $1.8bn | 13 | PMLiVE | ||
| Mi | Scenic Biotech, Bristol Myers Squibb to develop new drug targets | 6 | Pharmaceutical Business Review | ||
| Mi | Should You Pick Bristol Myers Squibb Stock At $45? | 47 | Forbes | ||
| Di | Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits | 18 | FiercePharma | ||
| Di | Scenic Biotech Enters Research Collaboration with Bristol Myers Squibb | 6 | Contract Pharma | ||
| Di | A Closer Look at Bristol-Myers Squibb's Options Market Dynamics | 25 | Benzinga.com | ||
| Di | J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations | 11 | Seeking Alpha | ||
| Di | Repertoire and Bristol Myers Squibb link on autoimmune disease vaccines | 10 | Pharmaceutical Technology | ||
| Di | Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb | 220 | Business Wire | Bristol Myers Squibb gains access to Scenic's Cell-Seq technology platform to unlock the underlying genetic interactions of cellular pathways for undisclosed targets Scenic to receive an upfront... ► Artikel lesen | |
| Di | Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations | 14 | CNBC | ||
| Di | J&J, Bristol Myers lose challenges to US drug price negotiation program | 22 | Reuters | ||
| Mo | How Is The Market Feeling About Bristol-Myers Squibb? | 23 | Benzinga.com | ||
| Mo | Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact | 7 | Seeking Alpha | ||
| Mo | Repertoire pivot pays dividends with Bristol Myers deal | 16 | BioPharma Dive | ||
| Mo | Repertoire Immune Medicines In Strategic Partnership With Bristol Myers Squibb | 234 | AFX News | NEW YORK CITY (dpa-AFX) - Repertoire Immune Medicines Monday said it has entered strategic partnership with Bristol-Myers Squibb Company (BMY) to develop tolerizing vaccines for up to three... ► Artikel lesen | |
| Mo | Bristol Myers pays $65M to expand Repertoire of autoimmune assets | 14 | FierceBiotech | ||
| Mo | Repertoire Immune Medicines: Repertoire Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases | 74 | PR Newswire | Collaboration combines Repertoire's industry leading DECODE platform that uniquely maps the immune synapse to develop T cell targeted immune medicines with Bristol Myers Squibb's world-leading expertise... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 2.750 |
| NEL | 1.606 |
| APPLE | 1.483 |
| BYD | 1.430 |
| BAYER | 1.429 |
| SUPER MICRO COMPUTER | 1.319 |
| DEUTSCHE BANK | 1.208 |
| TUI | 1.186 |
| NVIDIA | 1.178 |
| PLUG POWER | 1.034 |
| TESLA | 981 |
| DAIMLER TRUCK | 922 |
| MERCEDES-BENZ | 889 |
| RHEINMETALL | 868 |
| RWE | 868 |
| AURUBIS | 785 |
| RENK GROUP | 769 |
| DEUTSCHE LUFTHANSA | 755 |
| VOLKSWAGEN | 742 |
| COMMERZBANK | 739 |
| AMAZON | 721 |
| SIEMENS ENERGY | 673 |
| AIXTRON SE | 647 |
| SIXT SE VZ | 636 |
| BASF | 597 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
